HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease.

Abstract
Various types of stress, such as disruption of calcium homeostasis, inhibition of protein glycosylation and reduction of disulfide bonds, result in accumulation of misfolded proteins in the endoplasmic reticulum (ER). The initial cellular response involves removal of such proteins by the ER, but excessive and/or long-term stress results in apoptosis. In this study, we used a randomized ribozyme library and ER stress-mediated apoptosis (tunicamycin-induced apoptosis) in SK-N-SH human neuroblastoma cells as a selective phenotype to identify factors involved in this process. We identified a double-stranded RNA-dependent protein kinase (PKR) as one of the participants in this process. The level of nuclear PKR was elevated, but the level of cytoplasmic PKR barely changed in tunicamycin-treated SK-N-SH cells. Furthermore, tunicamycin also raised levels of phosphorylated PKR in the nucleus. We also detected the accumulation of phosphorylated PKR in the nuclei of autopsied brain tissues in Alzheimer's disease. Thus, PKR might play a role in ER stress-induced apoptosis and in Alzheimer's disease.
AuthorsReiko Onuki, Yoshio Bando, Eigo Suyama, Taiichi Katayama, Hiroaki Kawasaki, Tadashi Baba, Masaya Tohyama, Kazunari Taira
JournalThe EMBO journal (EMBO J) Vol. 23 Issue 4 Pg. 959-68 (Feb 25 2004) ISSN: 0261-4189 [Print] England
PMID14765129 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Catalytic
  • Tunicamycin
  • eIF-2 Kinase
Topics
  • Aged
  • Alzheimer Disease (metabolism)
  • Apoptosis
  • Brain (metabolism)
  • Cell Nucleus (metabolism)
  • Cytoplasm (metabolism)
  • Endoplasmic Reticulum (metabolism)
  • Humans
  • Phosphorylation
  • RNA, Catalytic (genetics)
  • Signal Transduction
  • Tumor Cells, Cultured
  • Tunicamycin (pharmacology)
  • eIF-2 Kinase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: